SPINEART has signed a distribution agreement with Sanofi-Aventis in Germany. Sanofi-Aventis, a leading global pharmaceutical company, is setting up a dedicated spine implant business to become one of the key players in the German spinal market, answering to the needs of the surgeons in the expected high quality manner. Germany is the biggest European market for spinal implants and the 3rd biggest market worldwide.